Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01428206
Other study ID # LCP001
Secondary ID
Status Completed
Phase N/A
First received August 23, 2011
Last updated June 13, 2013
Start date June 2009
Est. completion date December 2012

Study information

Verified date June 2013
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.


Description:

All residential care homes in SkellefteƄ municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 260
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- nursing homes in SkellefteƄ municipality, Sweden

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Liverpool care pathway
Liverpool care pathway is started tha last day in life for elderly at nursing homes

Locations

Country Name City State
Sweden Skellefteå municipality Skellefteå Västerbotten

Sponsors (1)

Lead Sponsor Collaborator
Umeå University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of care changes between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative one month to six months after the relatives death Yes
Secondary place of death changes between the groups the time of death Yes
Secondary drug consumption the last three days before death Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04094428 - Burden, Mortality and Supply Costs in Intensive Care Unit Patients
Active, not recruiting NCT04487054 - Outcomes of Early Palliative Care Intervention for High-Risk Patients in the Intensive Care Unit-A Pilot Study N/A
Active, not recruiting NCT05994430 - The Effect of End-of-Life Care Awareness Education on Knowledge, Attitudes, and Behaviors of Intensive Care Nurses: A Randomized Controlled Study N/A
Recruiting NCT06026241 - Practice Analysis of Care, Paraclinical Exams and Treatments Received by Geriatric Patients Both During the Last Week and the Last 24 Hours of Their Lives.
Enrolling by invitation NCT03440606 - A Novel Mindful-Compassion Art Therapy (MCAT) Supervision N/A
Completed NCT04919941 - A Guide to Conservative Care N/A